Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
NCT01908517 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 522
Last updated 2016-05-25
Summary
There has been very limited research that has looked at electronic reminders (text messages) and its effectiveness in adherence to vaccination among low-income minority populations. Results have shown that text messages, among low-income parents and adolescents who were identified as having a cellphone, is an effective strategy to increase the likelihood of adolescent vaccination adherence. Hard copy and electronic messaging reminders have also been proven to be effective when coupled with other prevention strategies for immunizations for influenza and pneumococcal pneumonia and screening for colon, breast, and cervical cancer in adults. Additionally, Merck and Co. recommend electronic reminders in their patient compliance program as a key strategy for adherence. To our knowledge, this community-based pilot intervention study will be the first to assess electronic reminders and HPV vaccine initiation and adherence among rural uninsured and Medicaid populations. The investigators hypothesize that adolescent whose parents who receive the intervention will be more likely to initiate HPV vaccination and be compliant at 3 months and at 7 months as compared to the control group.
Conditions
- Patient Compliance
Interventions
- BEHAVIORAL
-
HPV Vaccine Electronic Reminders
The intervention group will receive 4 education messages, 2 reminder/education messages, as well as 1 baseline and 1 final assessment survey. Control group participants will receive 2 contacts throughout the study, 1 at baseline and 1 at their final assessment survey. Up to two reminder contacts will be used if surveys are not completed for both intervention and control group participants. Preference for receipt of reminders will be obtained from the information study card parents complete at study enrollment. Enrollment card content, educational messages and patient- reminders will all be developed with community input.
Sponsors & Collaborators
-
East Carolina University
lead OTHER
Principal Investigators
-
Essie Torres, PhD, MPH · East Carolina University
-
Alice Richman, PhD, MPH · East Carolina University
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 9 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- United States
Study Locations
More Related Trials
-
HPV IIS Reminder/Recall- New York State
NCT03057379 ·Status: COMPLETED ·Phase: NA
-
Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination
NCT05148559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
HPV Centralized R/R RCT #2 - New York State
NCT03294551 ·Status: COMPLETED ·Phase: NA
-
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tailoring of Vaccine-Focused Messages: Disease Salience
NCT03002324 ·Status: COMPLETED ·Phase: NA
-
Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
NCT06513494 ·Status: RECRUITING ·Phase: NA
-
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
NCT02145156 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
HPV Vaccine Reminders - SEARCH II Study
NCT06161831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Communication Strategies to Increase HPV Vaccination Intention
NCT06784960 ·Status: COMPLETED ·Phase: NA
-
AFIX to Improve HPV Vaccination
NCT02370459 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
NCT02888418 ·Status: UNKNOWN ·Phase: PHASE1
-
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
NCT03759236 ·Status: COMPLETED ·Phase: NA
-
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821 ·Status: COMPLETED ·Phase: PHASE4
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062 ·Status: COMPLETED ·Phase: NA
-
State Immunization Information Systems to Improve HPV Vaccination Rates
NCT02993965 ·Status: COMPLETED ·Phase: NA
-
Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
NCT02968420 ·Status: COMPLETED ·Phase: PHASE4
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
NCT06854354 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
NCT03813940 ·Status: COMPLETED ·Phase: PHASE1
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Narrative Communication Intervention to Increase Human Papillomavirus Vaccination Intentions and Uptake
NCT05352308 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA